rs2330991

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM1BS2_Supporting

The NM_000496.3(CRYBB2):​c.433C>T​(p.Arg145Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,614,124 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R145P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

CRYBB2
NM_000496.3 missense

Scores

6
9
4

Clinical Significance

Uncertain significance no assertion criteria provided U:1

Conservation

PhyloP100: 0.137
Variant links:
Genes affected
CRYBB2 (HGNC:2398): (crystallin beta B2) Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Beta-crystallins, the most heterogeneous, differ by the presence of the C-terminal extension (present in the basic group, none in the acidic group). Beta-crystallins form aggregates of different sizes and are able to self-associate to form dimers or to form heterodimers with other beta-crystallins. This gene, a beta basic group member, is part of a gene cluster with beta-A4, beta-B1, and beta-B3. A chain-terminating mutation was found to cause type 2 cerulean cataracts. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 3 uncertain in NM_000496.3
BS2
High AC in GnomAd4 at 5 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CRYBB2NM_000496.3 linkuse as main transcriptc.433C>T p.Arg145Trp missense_variant 5/6 ENST00000398215.3
CRYBB2XM_006724141.4 linkuse as main transcriptc.433C>T p.Arg145Trp missense_variant 5/6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CRYBB2ENST00000398215.3 linkuse as main transcriptc.433C>T p.Arg145Trp missense_variant 5/61 NM_000496.3 P1
CRYBB2ENST00000651629.1 linkuse as main transcriptc.433C>T p.Arg145Trp missense_variant 5/6 P1

Frequencies

GnomAD3 genomes
AF:
0.0000328
AC:
5
AN:
152260
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000723
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000137
AC:
20
AN:
1461864
Hom.:
0
Cov.:
32
AF XY:
0.0000138
AC XY:
10
AN XY:
727228
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000126
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.0000328
AC:
5
AN:
152260
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74388
show subpopulations
Gnomad4 AFR
AF:
0.0000723
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000501
Hom.:
0
ExAC
AF:
0.0000494
AC:
6

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

CRYBB2-related disorder Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesSep 05, 2024The CRYBB2 c.433C>T variant is predicted to result in the amino acid substitution p.Arg145Trp. This variant along with two other missense variants in CRYBB2 (p.Gln147Arg and p.Thr150Met) have been reported in the heterozygous state in patients and families with congenital cataracts (Family CC00133 in Hansen et al. 2009. PubMed ID: 19182255; Garnai et al. 2014. PubMed ID: 25489230; Zhuang et al. 2019. PubMed ID: 31523120). Using primers specific to both CRYBB2 and its pseudogene (CRYBB2P1), Garnai et al. were able to show that the three variants resulted from a de novo gene conversion event involving the transfer of ~270 base pairs from the pseudogene to CRYBB2 (Garnai et al. 2014. PubMed ID: 25489230). This variant is reported in 0.0056% of alleles in individuals of Latino descent in gnomAD. Of note, another large family with congenital cataracts was reported to have the CRYBB2 p.Gln147Arg and p.Thr150Met variants without the p.Arg145Trp variant. This family also had additional variants in other cataract related genes (GJA3 and HSF4) (Lv et al. 2014. PubMed ID: 24637349). To our knowledge, studies analyzing the functional consequences of these variants either individually or in combination with one another have not been completed. At PreventionGenetics, we have detected the c.433C>T (p.Arg145Trp) and the c.440A>G (p.Gln147Arg) variants together in another patient undergoing testing for early-onset cataracts (Internal Data). Although we suspect that the c.433C>T (p.Arg145Trp) variant may be pathogenic, at this time, its clinical significance is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.46
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Pathogenic
0.17
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.75
D
Eigen
Uncertain
0.30
Eigen_PC
Benign
0.15
FATHMM_MKL
Benign
0.69
D
LIST_S2
Uncertain
0.96
D
M_CAP
Benign
0.073
D
MetaRNN
Uncertain
0.70
D
MetaSVM
Uncertain
0.56
D
MutationAssessor
Pathogenic
3.2
M
MutationTaster
Benign
1.0
D
PrimateAI
Pathogenic
0.89
D
PROVEAN
Pathogenic
-5.6
D
REVEL
Pathogenic
0.75
Sift
Uncertain
0.011
D
Sift4G
Uncertain
0.0020
D
Polyphen
1.0
D
Vest4
0.64
MutPred
0.56
Loss of disorder (P = 0.0262);
MVP
0.75
MPC
1.3
ClinPred
0.98
D
GERP RS
1.2
Varity_R
0.70

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2330991; hg19: chr22-25625529; API